AKAP4 mediated tumor malignancy in esophageal cancer

Shujun Li1, Xuebo Qin2, Yanjie Li3

  • 1Department of Thoracic Surgery, The Second Hospital of Hebei Medical University Shijiazhuang, China.

Insights

A-kinase anchor protein 4 (AKAP4) is elevated in esophageal cancer, promoting tumor growth and invasion. Inhibiting AKAP4 suppressed cancer progression in vitro and in vivo, highlighting its role as a potential therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • A-kinase anchor protein 4 (AKAP4) is a Cancer/Testis antigen found in germ cells and various tumors.
  • AKAP4 expression correlates with tumor malignancy, but its role in esophageal cancer is uncharacterized.

Purpose of the Study:

  • To investigate the function and clinical significance of AKAP4 in esophageal cancer.
  • To elucidate the regulatory mechanisms of AKAP4 expression in esophageal cancer cells.

Main Methods:

  • Quantitative analysis of AKAP4 mRNA and protein levels in esophageal cancer tissues and cell lines.
  • In vitro studies involving AKAP4 knockdown and overexpression in KYSE150 cells.
  • In vivo xenograft mouse model to assess tumor growth.
  • Analysis of epithelial and mesenchymal markers.
  • Chromatin immunoprecipitation to study NF-κB p65 binding to the AKAP4 promoter.

Main Results:

  • AKAP4 mRNA and protein levels were significantly upregulated in esophageal cancer tissues compared to normal controls.
  • AKAP4 inhibition suppressed esophageal cancer cell proliferation and invasion, while overexpression promoted these processes.
  • AKAP4 modulation affected the expression of epithelial-mesenchymal transition markers (E-cadherin, ZO-1, vimentin, N-cadherin).
  • Silencing AKAP4 suppressed tumor growth in vivo.
  • NF-κB p65 was identified as a regulator of AKAP4 expression.

Conclusions:

  • Overexpression of AKAP4 is associated with esophageal cancer progression and malignancy.
  • AKAP4 plays a crucial role in promoting esophageal cancer cell growth and invasion.
  • Targeting AKAP4 represents a potential therapeutic strategy for esophageal cancer.

Related Concept Videos

Barrett Esophagus-I: Introduction01:21

Barrett Esophagus-I: Introduction

Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
1.2K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K
Esophagus01:24

Esophagus

The esophagus, a muscular conduit linking the pharynx and stomach, measures roughly 10 inches (25.4 cm) and sits behind the trachea. It remains collapsed when not swallowing. The esophagus follows a predominantly straight path through the thoracic mediastinum and enters the abdominal cavity through a diaphragmatic opening known as the esophageal hiatus.
The movement of edibles from the pharynx into the esophagus is facilitated by the upper esophageal sphincter, which is formed primarily by the...
4.4K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.3K